Stoneridge’s Growth Potential and Market Resilience: A Buy Rating by Gary Prestopino

Tip Ranks
2025.11.14 17:15
portai
I'm PortAI, I can summarize articles.

Analyst Gary Prestopino of Barrington reiterated a Buy rating on Stoneridge, reducing the price target to $14.50. Despite macroeconomic pressures, Stoneridge showed strong Q3/25 financial performance, improved operating margins, and reduced quality-related costs. Strategic initiatives like the expansion of the MirrorEye program and new business wins in Control Devices highlight growth potential. The company's stock price increased by 12.82% over the past six months.

Analyst Gary Prestopino of Barrington reiterated a Buy rating on Stoneridge, reducing the price target to $14.50.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Gary Prestopino has given his Buy rating due to a combination of factors that highlight Stoneridge’s potential for growth and resilience in challenging market conditions. The company’s Q3/25 financial performance showed adjusted EBITDA figures that exceeded expectations when excluding non-operating foreign exchange expenses. Despite facing macroeconomic pressures that affected sales, Stoneridge managed to improve its operating margin and reduce quality-related costs significantly.
Moreover, Stoneridge’s strategic initiatives, such as the expansion of its MirrorEye program and new business wins in Control Devices, underscore its capacity to capture market opportunities. The substantial increase in MirrorEye sales, particularly in Europe and North America, and the securing of new program awards, including a significant OEM program, reflect the company’s strong positioning in the market. These developments, alongside the company’s robust backlog and successful cost management, contribute to the positive outlook that supports the Buy rating.

SRI’s price has also changed moderately for the past six months – from $5.150 to $5.810, which is a 12.82% increase.